UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Microbiology, pathogenesis, and epidemiology of relapsing fever

Author
Alan G Barbour, MD
Section Editor
Daniel J Sexton, MD
Deputy Editor
Jennifer Mitty, MD, MPH

INTRODUCTION

Relapsing fever, which is caused by spirochetes of the genus Borrelia, is characterized by recurrent episodes of fever that accompany spirochetemia. It is an arthropod-borne infection that occurs in two major forms: tick-borne and louse-borne [1,2].

Tick-borne relapsing fever is a zoonosis (ie, an animal disease that is transmissible to humans). The two main Borrelia spp involved in North America are Borrelia hermsii (in the mountainous West) and Borrelia turicatae (in the Southwest and South Central region). Other tick-borne species cause relapsing fever on other continents.

Louse-borne relapsing fever is caused by Borrelia recurrentis. It is principally a disease seen in the developing world. It is spread from person to person by the body louse and can result in large epidemics.

The microbiology, pathogenesis, and epidemiology of relapsing fever will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of this disorder, as well as a related spirochete, Borrelia miyamotoi, are discussed separately. (See "Borrelia miyamotoi infection" and "Clinical features, diagnosis, and management of relapsing fever".)

MICROBIOLOGY

Genome and taxonomy — The agents of relapsing fever are spirochetes, a morphologically unique group of bacteria that differ substantially from both gram-negative and gram-positive organisms [3]. Spirochetes can cause a diverse group of diseases, including syphilis, leptospirosis, Lyme disease, and B. miyamotoi infection. (See "Syphilis: Epidemiology, pathophysiology, and clinical manifestations in HIV-uninfected patients" and "Epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis" and "Epidemiology of Lyme disease".)

                     
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Sep 2017. | This topic last updated: Aug 29, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Barbour A. Relapsing fever. In: Tick-borne Diseases of Humans, Dennis DT, Goodman JL, Sonenshine DE (Eds), ASM Press, Washington DC 2005. p.220.
  2. Barbour AG, Guo BP. Borrelia. In: Molecular Biology, Host Interaction, and Pathogenesis, Samuels DS, Radolf JD (Eds), Caister Academic Press, Norfolk, United Kingdom 2010. p.333.
  3. Paster BJ, Dewhirst FE, Weisburg WG, et al. Phylogenetic analysis of the spirochetes. J Bacteriol 1991; 173:6101.
  4. Barbour AG. Phylogeny of a relapsing fever Borrelia species transmitted by the hard tick Ixodes scapularis. Infect Genet Evol 2014; 27:551.
  5. Ras NM, Lascola B, Postic D, et al. Phylogenesis of relapsing fever Borrelia spp. Int J Syst Bacteriol 1996; 46:859.
  6. Barbour AG, Adeolu M, Gupta RS. Division of the genus Borrelia into two genera (corresponding to Lyme disease and relapsing fever groups) reflects their genetic and phenotypic distinctiveness and will lead to a better understanding of these two groups of microbes (Margos et al. (2016) There is inadequate evidence to support the division of the genus Borrelia. Int. J. Syst. Evol. Microbiol. doi: 10.1099/ijsem.0.001717). Int J Syst Evol Microbiol 2017.
  7. Kisinza WN, McCall PJ, Mitani H, et al. A newly identified tick-borne Borrelia species and relapsing fever in Tanzania. Lancet 2003; 362:1283.
  8. Lescot M, Audic S, Robert C, et al. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 2008; 4:e1000185.
  9. Ferdows MS, Barbour AG. Megabase-sized linear DNA in the bacterium Borrelia burgdorferi, the Lyme disease agent. Proc Natl Acad Sci U S A 1989; 86:5969.
  10. Casjens S. Evolution of the linear DNA replicons of the Borrelia spirochetes. Curr Opin Microbiol 1999; 2:529.
  11. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986; 50:381.
  12. Holt SC. Anatomy and chemistry of spirochetes. Microbiol Rev 1978; 42:114.
  13. Barbour AG. Relapsing Fever and Other Borrelia Infections. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.295.
  14. Takayama K, Rothenberg RJ, Barbour AG. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 1987; 55:2311.
  15. Hardy PH Jr, Levin J. Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc Soc Exp Biol Med 1983; 174:47.
  16. Hirschfeld M, Kirschning CJ, Schwandner R, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999; 163:2382.
  17. Londoño D, Cadavid D. Bacterial lipoproteins can disseminate from the periphery to inflame the brain. Am J Pathol 2010; 176:2848.
  18. Barbour AG, Putteet-Driver AD, Bunikis J. Horizontally acquired genes for purine salvage in Borrelia spp. causing relapsing fever. Infect Immun 2005; 73:6165.
  19. Pettersson J, Schrumpf ME, Raffel SJ, et al. Purine salvage pathways among Borrelia species. Infect Immun 2007; 75:3877.
  20. Zhong J, Skouloubris S, Dai Q, et al. Function and evolution of plasmid-borne genes for pyrimidine biosynthesis in Borrelia spp. J Bacteriol 2006; 188:909.
  21. Schwan TG, Battisti JM, Porcella SF, et al. Glycerol-3-phosphate acquisition in spirochetes: distribution and biological activity of glycerophosphodiester phosphodiesterase (GlpQ) among Borrelia species. J Bacteriol 2003; 185:1346.
  22. Schwan TG, Schrumpf ME, Hinnebusch BJ, et al. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis. J Clin Microbiol 1996; 34:2483.
  23. Kelly R. Cultivation of Borrelia hermsi. Science 1971; 173:443.
  24. Stoenner HG. Biology of Borrelia hermsii in Kelly medium. Appl Microbiol 1974; 28:540.
  25. Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 1984; 57:521.
  26. Cutler SJ, Akintunde CO, Moss J, et al. Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis. Int J Syst Bacteriol 1999; 49 Pt 4:1793.
  27. Colebunders R, De Serrano P, Van Gompel A, et al. Imported relapsing fever in European tourists. Scand J Infect Dis 1993; 25:533.
  28. Colomba C, Scarlata F, Di Carlo P, et al. Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article. Public Health 2016; 139:22.
  29. Hoch M, Wieser A, Löscher T, et al. Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015. Euro Surveill 2015; 20.
  30. Banerjee SN, Banerjee M, Fernando K, et al. Tick-borne relapsing fever in British Columbia, Canada: first isolation of Borrelia hermsii. J Clin Microbiol 1998; 36:3505.
  31. Forrester JD, Kjemtrup AM, Fritz CL, et al. Tickborne relapsing fever - United States, 1990-2011. MMWR Morb Mortal Wkly Rep 2015; 64:58.
  32. Trape JF, Diatta G, Arnathau C, et al. The epidemiology and geographic distribution of relapsing fever borreliosis in West and North Africa, with a review of the Ornithodoros erraticus complex (Acari: Ixodida). PLoS One 2013; 8:e78473.
  33. Schwan TG, Anderson JM, Lopez JE, et al. Endemic foci of the tick-borne relapsing fever spirochete Borrelia crocidurae in Mali, West Africa, and the potential for human infection. PLoS Negl Trop Dis 2012; 6:e1924.
  34. Souidi Y, Boudebouch N, Ezikouri S, et al. Borrelia crocidurae in Ornithodoros ticks from northwestern Morocco: a range extension in relation to climatic change? J Vector Ecol 2014; 39:316.
  35. Cutler SJ, Bonilla EM, Singh RJ. Population structure of East African relapsing fever Borrelia spp. Emerg Infect Dis 2010; 16:1076.
  36. Vial L, Diatta G, Tall A, et al. Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet 2006; 368:37.
  37. Assous MV, Wilamowski A. Relapsing fever borreliosis in Eurasia--forgotten, but certainly not gone! Clin Microbiol Infect 2009; 15:407.
  38. Sarih M, Garnier M, Boudebouch N, et al. Borrelia hispanica relapsing fever, Morocco. Emerg Infect Dis 2009; 15:1626.
  39. Toledo A, Anda P, Escudero R, et al. Phylogenetic analysis of a virulent Borrelia species isolated from patients with relapsing fever. J Clin Microbiol 2010; 48:2484.
  40. Colin de Verdiere N, Hamane S, Assous MV, et al. Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan. Emerg Infect Dis 2011; 17:1325.
  41. Moemenbellah-Fard MD, Benafshi O, Rafinejad J, Ashraf H. Tick-borne relapsing fever in a new highland endemic focus of western Iran. Ann Trop Med Parasitol 2009; 103:529.
  42. Halperin T, Orr N, Cohen R, et al. Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Trop 2006; 98:189.
  43. Yimer M, Abera B, Mulu W, et al. Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city Northwest, Ethiopia. BMC Res Notes 2014; 7:615.
  44. Cutler SJ. Possibilities for relapsing fever reemergence. Emerg Infect Dis 2006; 12:369.
  45. Bryceson AD, Parry EH, Perine PL, et al. Louse-borne relapsing fever. Q J Med 1970; 39:129.
  46. Antinori S, Mediannikov O, Corbellino M, Raoult D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis 2016; 14:110.
  47. Osthoff M, Schibli A, Fadini D, et al. Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. BMC Infect Dis 2016; 16:210.
  48. Brouqui P, Stein A, Dupont HT, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore) 2005; 84:61.
  49. Jongen VH, van Roosmalen J, Tiems J, et al. Tick-borne relapsing fever and pregnancy outcome in rural Tanzania. Acta Obstet Gynecol Scand 1997; 76:834.
  50. Larsson C, Andersson M, Guo BP, et al. Complications of pregnancy and transplacental transmission of relapsing-fever borreliosis. J Infect Dis 2006; 194:1367.
  51. Centers for Disease Control and Prevention (CDC). Tickborne relapsing fever in a mother and newborn child--Colorado, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:174.
  52. López-Cortés L, Lozano de León F, Gómez-Mateos JM, et al. Tick-borne relapsing fever in intravenous drug abusers. J Infect Dis 1989; 159:804.
  53. Burgdorfer W, Varma MG. Trans-stadial and transovarial development of disease agents in arthropods. Annu Rev Entomol 1967; 12:347.
  54. Rollend L, Fish D, Childs JE. Transovarial transmission of Borrelia spirochetes by Ixodes scapularis: a summary of the literature and recent observations. Ticks Tick Borne Dis 2013; 4:46.
  55. Sonenshine DE, Anderson JM. Biology of Ticks, Sonenshine DE, Roe RM (Eds), Oxford University Press, New York City 2014.
  56. Manzano-Roman R, Diaz-Martin V, de la Fuente J, Perez-Sanchez R. Soft ticks as pathogen vectors: Distribution, surveillance and control. In: Parasitology, Shah MM (Ed), InTech, Rijeka 2012.
  57. Dworkin MS, Schwan TG, Anderson DE Jr. Tick-borne relapsing fever in North America. Med Clin North Am 2002; 86:417.
  58. Wilder HK, Wozniak E, Huddleston E, et al. Case report: A retrospective serological analysis indicating human exposure to tick-borne relapsing fever spirochetes in Texas. PLoS Negl Trop Dis 2015; 9:e0003617.
  59. Christensen J, Fischer RJ, McCoy BN, et al. Tickborne relapsing fever, Bitterroot Valley, Montana, USA. Emerg Infect Dis 2015; 21:217.
  60. Masoumi Asl H, Goya MM, Vatandoost H, et al. The epidemiology of tick-borne relapsing fever in Iran during 1997-2006. Travel Med Infect Dis 2009; 7:160.
  61. Foley JE, Nieto NC. The ecology of tick-transmitted infections in the redwood chipmunk (Tamias ochrogenys). Ticks Tick Borne Dis 2011; 2:88.
  62. Bonilla DL, Durden LA, Eremeeva ME, Dasch GA. The biology and taxonomy of head and body lice--implications for louse-borne disease prevention. PLoS Pathog 2013; 9:e1003724.
  63. Boutellis A, Abi-Rached L, Raoult D. The origin and distribution of human lice in the world. Infect Genet Evol 2014; 23:209.
  64. Boutellis A, Mediannikov O, Bilcha KD, et al. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis 2013; 19:796.
  65. SCHUHARDT VT, WILKERSON M. Relapse phenomena in rats infected with single spirochetes (Borrelia recurrentis var. turicatae). J Bacteriol 1951; 62:215.
  66. Cadavid D, Bundoc V, Barbour AG. Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis 1993; 168:143.
  67. Cadavid D, Thomas DD, Crawley R, Barbour AG. Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 1994; 179:631.
  68. Shamaei-Tousi A, Burns MJ, Benach JL, et al. The relapsing fever spirochaete, Borrelia crocidurae, activates human endothelial cells and promotes the transendothelial migration of neutrophils. Cell Microbiol 2000; 2:591.
  69. Barbour AG, Guo BP. Pathogenesis of relapsing fever. In: Molecular and Cellular Biology, Samuels F, Radolf J (Eds), Horizon Scientific Press, Norwich 2009.
  70. Stoenner HG, Dodd T, Larsen C. Antigenic variation of Borrelia hermsii. J Exp Med 1982; 156:1297.
  71. Dai Q, Restrepo BI, Porcella SF, et al. Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol 2006; 60:1329.
  72. Coffey EM, Eveland WC. Experimental relapsing fever initiated by Borrelia hermsi. II. Sequential appearance of major serotypes in the rat. J Infect Dis 1967; 117:29.
  73. Barbour AG, Dai Q, Restrepo BI, et al. Pathogen escape from host immunity by a genome program for antigenic variation. Proc Natl Acad Sci U S A 2006; 103:18290.
  74. Barbour AG, Bundoc V. In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun 2001; 69:1009.
  75. Barbour AG, Tessier SL, Stoenner HG. Variable major proteins of Borrellia hermsii. J Exp Med 1982; 156:1312.
  76. Burman N, Bergström S, Restrepo BI, Barbour AG. The variable antigens Vmp7 and Vmp21 of the relapsing fever bacterium Borrelia hermsii are structurally analogous to the VSG proteins of the African trypanosome. Mol Microbiol 1990; 4:1715.
  77. Restrepo BI, Kitten T, Carter CJ, et al. Subtelomeric expression regions of Borrelia hermsii linear plasmids are highly polymorphic. Mol Microbiol 1992; 6:3299.
  78. Kitten T, Barbour AG. Juxtaposition of expressed variable antigen genes with a conserved telomere in the bacterium Borrelia hermsii. Proc Natl Acad Sci U S A 1990; 87:6077.
  79. Plasterk RH, Simon MI, Barbour AG. Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii. Nature 1985; 318:257.
  80. Barbour AG, Burman N, Carter CJ, et al. Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 1991; 5:489.
  81. Restrepo BI, Carter CJ, Barbour AG. Activation of a vmp pseudogene in Borrelia hermsii: an alternate mechanism of antigenic variation during relapsing fever. Mol Microbiol 1994; 13:287.
  82. Restrepo BI, Barbour AG. Antigen diversity in the bacterium B. hermsii through "somatic" mutations in rearranged vmp genes. Cell 1994; 78:867.
  83. Schwan TG, Hinnebusch BJ. Bloodstream- versus tick-associated variants of a relapsing fever bacterium. Science 1998; 280:1938.
  84. Schwan TG, Piesman J. Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 2002; 8:115.
  85. Carter CJ, Bergström S, Norris SJ, Barbour AG. A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun 1994; 62:2792.
  86. Porcella SF, Raffel SJ, Anderson DE Jr, et al. Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America. Infect Immun 2005; 73:6647.
  87. Shamaei-Tousi A, Collin O, Bergh A, Bergström S. Testicular damage by microcirculatory disruption and colonization of an immune-privileged site during Borrelia crocidurae infection. J Exp Med 2001; 193:995.
  88. Shamaei-Tousi A, Martin P, Bergh A, et al. Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli. J Infect Dis 1999; 180:1929.
  89. Hovis KM, McDowell JV, Griffin L, Marconi RT. Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 2004; 186:2612.
  90. Rossmann E, Kraiczy P, Herzberger P, et al. Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J Immunol 2007; 178:7292.
  91. Lewis ER, Marcsisin RA, Campeau Miller SA, et al. Fibronectin-binding protein of Borrelia hermsii expressed in the blood of mice with relapsing fever. Infect Immun 2014; 82:2520.
  92. Southern P, Sanford J. Relapsing fever: A clinical and microbiological review. Medicine 1969; 48:129.
  93. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998; 26:151.
  94. Duray PH. The surgical pathology of human Lyme disease. An enlarging picture. Am J Surg Pathol 1987; 11 Suppl 1:47.
  95. Pennington PM, Allred CD, West CS, et al. Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun 1997; 65:285.
  96. Park HK, Jones BE, Barbour AG. Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies. J Am Acad Dermatol 1986; 15:406.
  97. Barbour AG. Relapsing fever. In: Harrison's Principle of Internal Medicine, 19th ed, Kasper DL, Hauser SL, Longo DL, et al (Eds), McGraw Hill, New York City 2015.
  98. Elbir H, Henry M, Diatta G, et al. Multiplex real-time PCR diagnostic of relapsing fevers in Africa. PLoS Negl Trop Dis 2013; 7:e2042.
  99. Newman K Jr, Johnson RC. T-cell-independent elimination of Borrelia turicatae. Infect Immun 1984; 45:572.
  100. LaRocca TJ, Katona LI, Thanassi DG, Benach JL. Bactericidal action of a complement-independent antibody against relapsing fever Borrelia resides in its variable region. J Immunol 2008; 180:6222.
  101. Barbour AG. Immunobiology of relapsing fever. Contrib Microbiol Immunol 1987; 8:125.
  102. Bryceson AD. Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis 1976; 133:696.
  103. Negussie Y, Remick DG, DeForge LE, et al. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med 1992; 175:1207.